Soper DE, Brockwell NJ, Dalton HP. Evaluation of the effects of a female condom on the female genital tract. Contraception 1991;44:21–29.
43.
Wilkinson D, Tholandi M, Ramjee G, et al. Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomized controlled trials including more than 5,000 women. Lancet Infect Dis 2002;2:613–617.
44.
Malyk B. Nonoxynol-9: evaluation of vaginal absorption in humans. Raritan, NJ: Ortho Pharmaceutical, 1983.
45.
Linn S, Schoenbaum SC, Monson RR, et al. Lack of association between contraceptive usage and congenital malformation in offspring. Am J Obstet Gynecol 1983;147:923–928.
46.
Harlap S, Shiono PH, Ramcharon S, et al. Chromosomal abnormalities in the Kaiser-Permanente birth defects study, with special reference to contraceptive use around the time of conception. Teratology 1985;31:381–387.
47.
Hooton TM, Hillier S, Johnson C, et al. Escherichia coli bacteriuria and contraceptive method. JAMA 1991;265:64–69.
48.
van der Straten A, Kang MS, Posner SF, et al. Predictors of diaphragm use as a potential sexually transmitted disease/HIV prevention method in Zimbabwe. Sex Transm Dis 2005;32:64–71.
49.
Hooton TM, Scholes D, Huges JP, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996;335:468–474.
50.
Davis JP, Chesney J, Wand PJ, et al. Toxic shock syndrome: epidemiologic features, recurrence, risk factors and prevention. N Engl J Med 1980;303:1429–1435.
51.
Shihata AA, Gollub E. Acceptability of a new intravaginal barrier contraceptive device (Femcap) Contraception 1992;46:511–519.
52.
U.S. Food and Drug Administration. US FDA FemCap Physician Labeling. Available online at: www.accessdata.fda.gov/cdrh docs/ pdf2/P020041c.pdf 53.
Yranski PA, Gamache ME. New options for barrier contraception. JOGNN 2008; 37:384–89.
54.
U.S. Food and Drug Administration. US FDA Lea’s Shield Physician Labeling. Available online at: www.accessdata.fda.gov/ cdrh docs/pdf/P010043c.pdf 55.
Hatcher RA, Trussell J, Stewart F, et al. Contraceptive technology. New York: Ardent Media, 2004.
56.
Borko E, McIntyre SL, Feldblum PJ. A comparative clinical trial of the contraceptive sponge and Neo Sampoon tablets. Obstet Gynecol 1985;654:511–515.
57.
United Nations. World contraceptive use, 2007. New York: United Nations Publications, 2007.
58.